Patents by Inventor Michael Cawthorne

Michael Cawthorne has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • TETRAHYDROCANNABIVARIN (THC) FOR USE IN THE PROTECTION OF PANCREATIC ISLET CELLS
    Publication number: 20160243075
    Abstract: The present invention relates to the phytocannabinoid tetrahydrocannabivarin (THCV) for use in the protection of pancreatic islet cells. Preferably the pancreatic islet cells to be protected are beta cells. More preferably the protection of the pancreatic islet cells maintains insulin production at levels which are able to substantially control or improve control of blood glucose levels in a patient.
    Type: Application
    Filed: May 16, 2014
    Publication date: August 25, 2016
    Inventors: Michael Cawthorne, Colin Stott, Stephen Wright
  • TETRAHYDROCANNABIVARIN (THCV) FOR USE IN THE PROTECTION OF PANCREATIC ISLET CELLS
    Publication number: 20160015682
    Abstract: The present invention relates to the phytocannabinoid tetrahydrocannabivarin (THCV) for use in the protection of pancreatic islet cells. Preferably the pancreatic islet cells to be protected are beta cells. More preferably the protection of the pancreatic islet cells maintains insulin production at levels which are able to substantially control or improve control of blood glucose levels in a patient.
    Type: Application
    Filed: November 20, 2012
    Publication date: January 21, 2016
    Applicant: GW Pharma Limited
    Inventors: Michael Cawthorne, Colin Stott, Stephen Wright
  • TETRAHYDROCANNABIVARIN (THCV) FOR USE IN THE PROTECTION OF PANCREATIC ISLET CELLS
    Publication number: 20140335208
    Abstract: The present invention relates to the phytocannabinoid tetrahydrocannabivarin (THCV) for use in the protection of pancreatic islet cells. Preferably the pancreatic islet cells to be protected are beta cells. More preferably the protection of the pancreatic islet cells maintains insulin production at levels which are able to substantially control or improve control of blood glucose levels in a patient.
    Type: Application
    Filed: November 20, 2012
    Publication date: November 13, 2014
    Inventors: Michael Cawthorne, Colin Stott, Stephen Wright
  • SOMATOSTATIN AND SOMATOSTATIN AGONISTS FOR TREATING INSULIN INSENSITIVITY AND SYNDROME X
    Publication number: 20080020974
    Abstract: The present invention relates to a method of treating insulin resistance or Syndrome X. The method includes the step of administering a therapeutically effective amount of a somatostatin or a somatostatin agonist to said patient. The invention also includes pharmaceutical compositions comprising a somatostatin or somatostatin agonist and the use of such products in the preparation of such compositions.
    Type: Application
    Filed: August 2, 2007
    Publication date: January 24, 2008
    Inventors: Michael Cawthorne, Yong-Ling Liu, Matthew Sennitt
  • Somatostatin and somatostatin agonists for decreasing body weight
    Publication number: 20060205647
    Abstract: The present invention relates to a method of decreasing body weight in a patient. The method includes the step of administering a therapeutically effective amount of a somatostatin or a somatostatin agonist ot said patient. A pharmaceutical/cosmetic composition comprises the somatostatin or somatostatin agonist. Such products are used to prepare such compositions for the reduction or body weight in a human or mammalian animal.
    Type: Application
    Filed: November 29, 2005
    Publication date: September 14, 2006
    Inventors: Michael Cawthorne, Yong-Ling Liu, Matthew Sennitt
  • Extracts, compounds and pharmaceutical compositions having anti-diabetic activity and their use
    Publication number: 20060159779
    Abstract: The invention relates inter alia to pharmaceutical compositions containing an extract obtainable from a plant of the genus Trichocaulon or Hoodia having anti-diabetic activity; and to the use of such extracts and to compound (1) as herein defined and its analogues for the manufacture of medicaments having anti-diabetic activity.
    Type: Application
    Filed: October 13, 2005
    Publication date: July 20, 2006
    Inventors: Ian Rubin, Jasjit Bindra, Michael Cawthorne
  • Use of leptin antagonists for the treatment of diabetes
    Publication number: 20040048773
    Abstract: The use of an antagonist of leptin for the manufacture of a medicament for the treamtne tof disorders resulting from deficiencies in insulin secretion, hyperglycaemia and insulin resistance.
    Type: Application
    Filed: October 17, 2002
    Publication date: March 11, 2004
    Applicant: SmithKline Beecham p.l.c.
    Inventors: Michael Cawthorne, Valur Emilsson, Yong-Ling Liu
  • Use of leptin antagonists for the treatment of diabetes
    Publication number: 20020160935
    Abstract: The use of an antagonist of leptin for the manufacture of a medicament for the treatment of disorders resulting from deficiencies in insulin secretion, hyperglycaemia and insulin resistance.
    Type: Application
    Filed: April 26, 2002
    Publication date: October 31, 2002
    Applicant: SmithKline Beecham plc
    Inventors: Michael Cawthorne, Valur Emilsson, Yong-Ling Liu
  • Use of leptin antagonists for the treatment of diabetes
    Publication number: 20020002181
    Abstract: The use of an antagonist of leptin for the manufacture of a medicament for the treatment of disorders resulting from deficiencies in insulin secretion, hyperglycaemia and insulin resistance.
    Type: Application
    Filed: August 6, 2001
    Publication date: January 3, 2002
    Inventors: Michael Cawthorne, Valur Emilsson, Yong-Ling Liu